LP-062 Two-year outcomes by belimumab additive on standard of care in patients with systemic lupus erythematosus: a single center retrospective cohort study

• Yu Matsueda,
• Yoshiyuki Arinuma,
• Yasuhiro Hasegawa,
• Kenji Oku,
• Kunihiro Yamaoka,
• Tomoki Tanaka,
• Tatsuhiko Wada,
• Hirotomo Asakura

Affiliations

Yu Matsueda

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Yoshiyuki Arinuma

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Yasuhiro Hasegawa

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Kenji Oku

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Kunihiro Yamaoka

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Tomoki Tanaka

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Tatsuhiko Wada

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

Hirotomo Asakura

Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan